Clinical Trial Results:
A Phase 3, Open-Label, Crossover Study to Evaluate the
Efficacy and Safety of Human Insulin Inhalation Powder
(HIIP) Compared with Once-Daily Insulin Glargine in
Insulin-Naïve Patients with Type 2 Diabetes Mellitus on
Oral Agents
Summary
|
|
EudraCT number |
2006-005383-51 |
Trial protocol |
ES |
Global completion date |
29 May 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 Nov 2016
|
First version publication date |
30 Nov 2016
|
Other versions |
|
Summary report(s) |
IDAZ Approved CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.